240 related articles for article (PubMed ID: 18972268)
1. Biomedical research and the commercialization agenda: a review of main considerations for neuroscience.
Caulfield T; Ogbogu U
Account Res; 2008; 15(4):303-20. PubMed ID: 18972268
[TBL] [Abstract][Full Text] [Related]
2. Patenting basic research: myths and realities.
Kirschenbaum SR
Nat Neurosci; 2002 Nov; 5 Suppl():1025-7. PubMed ID: 12403976
[No Abstract] [Full Text] [Related]
3. Sustainability and the balancing of the health care and innovation agendas: the commercialization of genetic research.
Caulfield T
Sask Law Rev; 2003; 66(2):629-45. PubMed ID: 15212021
[No Abstract] [Full Text] [Related]
4. In search of a compromised solution to the problem arising from patenting biomedical research tools.
Derzko NM
Santa Clara Comput High Technol Law J; 2004; 20(2):347-410. PubMed ID: 16493840
[No Abstract] [Full Text] [Related]
5. [Patent rights and the free research. The boundary between basic research and private sector is not longer razor-sharp].
Westerlund L
Lakartidningen; 2005 Sep 26-Oct 2; 102(39):2737. PubMed ID: 16245544
[No Abstract] [Full Text] [Related]
6. Marketing biotechnology with a Gallic flair.
Jouanneau AC
Nat Biotechnol; 2003 Jul; 21 Suppl():BE36-7. PubMed ID: 12874977
[No Abstract] [Full Text] [Related]
7. Conflict of interest in biomedical research.
Blumenthal D
Health Matrix Clevel; 2002; 12(2):377-92. PubMed ID: 12430361
[No Abstract] [Full Text] [Related]
8. Disclosure issues in neuroscience research.
Parker LS; Kienholz ML
Account Res; 2008; 15(4):226-41. PubMed ID: 18972264
[TBL] [Abstract][Full Text] [Related]
9. Patents, commercialization and the Canadian stem cell research community.
Caulfield T; Ogbogu U; Murdoch C; Einsiedel E
Regen Med; 2008 Jul; 3(4):483-96. PubMed ID: 18588471
[TBL] [Abstract][Full Text] [Related]
10. The paper trail to commercialization.
Kling J; DeFrancesco L
Nat Biotechnol; 2007 Nov; 25(11):1217-23. PubMed ID: 17989671
[TBL] [Abstract][Full Text] [Related]
11. Financial anatomy of neuroscience research.
Dorsey ER; Vitticore P; De Roulet J; Thompson JP; Carrasco M; Johnston SC; Holloway RG; Moses H
Ann Neurol; 2006 Dec; 60(6):652-9. PubMed ID: 17192926
[TBL] [Abstract][Full Text] [Related]
12. Does patenting genes change the meaning of life?
Thompson RE
Physician Exec; 2003; 29(3):40-2. PubMed ID: 12774726
[No Abstract] [Full Text] [Related]
13. A status report on neuroscience research, without grade inflation.
Johnston SC; Hauser SL
Ann Neurol; 2006 Dec; 60(6):A9-11. PubMed ID: 17192939
[No Abstract] [Full Text] [Related]
14. Financial anatomy of neuroscience research.
Fields H
Ann Neurol; 2008 Jan; 63(1):124. PubMed ID: 17474111
[No Abstract] [Full Text] [Related]
15. A modest proposal: toward improved access to biotechnology research tools by implementing a broad experimental use exception.
Hoffman DC
Cornell Law Rev; 2004 May; 89(4):993-1043. PubMed ID: 15174465
[No Abstract] [Full Text] [Related]
16. The attack of the clones: patent law and stem cell research.
Rimmer M
J Law Med; 2003 May; 10(4):488-505. PubMed ID: 12852321
[TBL] [Abstract][Full Text] [Related]
17. The ethical neuroscientist.
Nat Neurosci; 2008 Mar; 11(3):239. PubMed ID: 18301426
[No Abstract] [Full Text] [Related]
18. Global health. Public-private partnerships proliferate.
Cohen J
Science; 2006 Jan; 311(5758):167. PubMed ID: 16410497
[No Abstract] [Full Text] [Related]
19. Ethics in biomedical research: practical considerations.
Chakrabarty AM
Am J Bioeth; 2002; 2(4):53-4. PubMed ID: 12762927
[No Abstract] [Full Text] [Related]
20. Commercialization, patents and moral assessment of biotechnology products.
Hoedemaekers R
J Med Philos; 2001 Jun; 26(3):273-84. PubMed ID: 11445882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
